Reema Zeineldin

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. doi request reprint Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells
    Reema Zeineldin
    College of Pharmacy, Mechanical Engineering, University of New Mexico, Albuquerque, New Mexico 87131, USA
    Nano Lett 9:751-7. 2009
  2. pmc PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells
    Karen D Cowden Dahl
    Health Sciences Center, College of Pharmacy, University of New Mexico, MSC 09 5360, 87131 0001 Albuquerque, NM, USA
    Mol Cancer Res 5:413-21. 2007
  3. ncbi request reprint Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III
    Reema Zeineldin
    Program in Toxicology and Pharmacology, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131 0001, USA
    Mol Carcinog 45:851-60. 2006
  4. pmc The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2
    Reema Zeineldin
    College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA
    J Histochem Cytochem 58:529-41. 2010
  5. pmc Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
    Laurie G Hudson
    Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA
    Clin Exp Metastasis 25:643-55. 2008
  6. ncbi request reprint Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation
    Yan Ning
    Health Sciences Center, College of Pharmacy and Chemical and Nuclear Engineering Department, University of New Mexico, Albuquerque, NM 87131 0001, USA
    Cancer Res 65:9280-6. 2005
  7. ncbi request reprint Epithelial cell migration in response to epidermal growth factor
    Reema Zeineldin
    Department of Chemical and Nuclear Engineering, University of New Mexico, Albuquerque, USA
    Methods Mol Biol 327:147-58. 2006
  8. pmc Targeting the EGF receptor for ovarian cancer therapy
    Reema Zeineldin
    Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131 0001, USA
    J Oncol 2010:414676. 2010

Collaborators

  • Carolyn Y Muller
  • Laurie G Hudson
  • Karen D Cowden Dahl
  • M Sharon Stack
  • Yan Ning
  • Yueying Liu
  • Martina Rosenberg

Detail Information

Publications8

  1. doi request reprint Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells
    Reema Zeineldin
    College of Pharmacy, Mechanical Engineering, University of New Mexico, Albuquerque, New Mexico 87131, USA
    Nano Lett 9:751-7. 2009
    ..Since fragmentation is a likely consequence of ultrasonication, a technique commonly used to disperse SWNTs, this maybe a concern for certain applications such as drug delivery...
  2. pmc PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells
    Karen D Cowden Dahl
    Health Sciences Center, College of Pharmacy, University of New Mexico, MSC 09 5360, 87131 0001 Albuquerque, NM, USA
    Mol Cancer Res 5:413-21. 2007
    ..These results suggest that PEA3 is regulated by EGFR and that the elevated PEA3 expression detected in human ovarian cancer may divert cells to a more invasive phenotype by regulating MMP-9 and MMP-14...
  3. ncbi request reprint Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III
    Reema Zeineldin
    Program in Toxicology and Pharmacology, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131 0001, USA
    Mol Carcinog 45:851-60. 2006
    ..These findings suggest that EGFRvIII expression may regulate phenotypic plasticity in ovarian cancer and thereby contribute to more aggressive disease...
  4. pmc The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2
    Reema Zeineldin
    College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA
    J Histochem Cytochem 58:529-41. 2010
    ....
  5. pmc Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
    Laurie G Hudson
    Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA
    Clin Exp Metastasis 25:643-55. 2008
    ....
  6. ncbi request reprint Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation
    Yan Ning
    Health Sciences Center, College of Pharmacy and Chemical and Nuclear Engineering Department, University of New Mexico, Albuquerque, NM 87131 0001, USA
    Cancer Res 65:9280-6. 2005
    ..We conclude that EGFR-activating mutations, such as EGFRvIII, in ovarian cancer may contribute to a more aggressive disease...
  7. ncbi request reprint Epithelial cell migration in response to epidermal growth factor
    Reema Zeineldin
    Department of Chemical and Nuclear Engineering, University of New Mexico, Albuquerque, USA
    Methods Mol Biol 327:147-58. 2006
    ..There are numerous approaches for evaluating cell migratory response following EGF stimulation. Both qualitative and quantitative techniques will be presented in this chapter...
  8. pmc Targeting the EGF receptor for ovarian cancer therapy
    Reema Zeineldin
    Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131 0001, USA
    J Oncol 2010:414676. 2010
    ..This paper will discuss contributions of EGF receptor activation to ovarian cancer pathogenesis and the status of EGF receptor inhibitors and EGF receptor targeted therapies in ovarian cancer treatment...